Abbott i-STAT 1 Manuel page 429
Masquer les pouces
Voir aussi pour i-STAT 1:
- Guide de l'utilisateur (52 pages) ,
- Notice technique (16 pages) ,
- Guide d'utilisation (12 pages)
Publicité
Références
1.
D.S. Young, Effects of Drugs on Clinical Laboratory Tests, 3rd ed. (Washington, DC: American As-
sociation of Clinical Chemistry, 1990).
2.
B.E. Statland, Clinical Decision Levels for Lab Tests (Oradell, NJ: Medical Economic Books, 1987).
3.
CLSI. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. CLSI
document EP9-A [ISBN 1-56238-283-7]. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsyl-
vania 19087-1898 USA, 1995.
4.
P.J. Cornbleet and N. Gochman, "Incorrect Least-Squares Regression Coefficients in Method-
Comparison Analysis," Clinical Chemistry 25:3, 432 (1979).
5.
Clinical and Laboratory Standards Institute (CLSI). Interference Testing in Clinical Chemistry; Ap-
proved Guideline-Second Edition. CLSI document EP7-A2 (ISBN 1-56238-584-4). Clinical and
Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-
1898, USA 2005.
6.
Charles R.A, Bee Y.M, Eng P.H.K., Goh S.Y. Point of care blood ketone testing: screening for dia-
betic ketoacidosis at the emergency department. Singapore Med J 2007; 48 (11): 986.
7
Wendroth Scott M., Tiffany N. Heady, Doris M. Haverstick, Lorin M. Bachmann, Mitchell G. Scott,
.
James C. Boyd, and David E. Bruns. Falsely increased chloride and missed anion gap elevation
during treatment with sodium thiosulfate. Clinica Chimica Acta 2014; 431: 77–79.
i-STAT est une marque déposée du groupe de sociétés Abbott dans plusieurs pays. Vacutainer est une marque déposée de Becton Dickinson and
Company, Franklin Lakes, NJ, Etats-Unis. LX20 et CX9 sont des marques déposées de Beckman Coulter Incorporated, Fullerton, CA, Etats-Unis.
Dimension RxL-Xpand est une marque déposée de Dade Behring Inc., Deerfield, IL, Etats-Unis.
Rev. Date: 23-APR-18
Art: 714176-03R
BUN - 5
Publicité
